Thyrocare Q2 results: Profit falls as impairment charge weighs on earnings

Revenue rose 25.1% year-on-year to ₹271 crore from ₹217 crore, while EBITDA increased 25.1% to ₹89 crore from ₹71 crore. The EBITDA margin remained flat at 33% year-on-year.

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.cnbctv18.com)